Patent · US Expired

Gene therapy in coronary angioplasty and bypass

US6335010B1 · kind B1 · utility

0Cited by
13References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 1997
Grant dateJan 1, 2002
Priority date
Expiry dateJun 30, 2017

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Hemodynamic forces play a key role in inducing 2, theroscler-osis-implicated gene in Vascular endothelial cells. To ellcitate the signal transduction pathway leading to such gene expression, the effects of fluid shearing on the activities of upstream signaling molecules is reported here. Fluid shearing (shear stress=12 dynes/cm2) induced a transient and rapid activation of p21ras and preferentially activated c-jun NH2 terminal kinases (JNK 1, 2) over extracellular signal-regulated kinases (ERK-1, -2). Co-transfection of RasNI7, a dominant negative mutant of Ha-Ras, attenuated the shear-activated JNK and luciferase reporters driven by TPA-responsive elements. JNIK(K-R) and MEKK(K-M), the respective catalytically inactive mutants of JNKI and MEKK, also partially inhibited the shear-induced luciferase reporters. In contrast, Raf301, ERK(K71R), and ERK(K52R), the dominant negative mutants of Raf-1, ERK-1, and ERK-2, respectively, had little effects on the activities of these reporters. The activation of JNK was also correlated with an increased c-Jun transcriptional activity, which was attenuated by a negative mutant of Son of sevenless (Sos). Thus, mechanical stimulation exerted by fl…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.